Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Raymond James Maintains Strong Buy on KLRS Kalaris Therapeutics Inc Mar 2026
Raymond James has reiterated a “Strong Buy” rating for Kalaris Therapeutics Inc (KLRS) on March 09, 2026, though no new price target was disclosed. This signals continued confidence in Kalaris’s prospects despite limited analyst coverage and a modest market reaction of a 1.11% price change since the announcement. Investors are advised to monitor catalysts and the company’s financial health, with Meyka AI also grading KLRS with a “B” based on various market factors.